A型及B型肝炎疫苗與慢性腎臟病

Hepatitis A and B Vaccinations and Chronic Kidney Disease

邱蕙瑄(Huei-Hsuan Chiu) ； 吳珮瑜(Pei-Yu Wu)

《腎臟與透析》 33卷1期 (2021/03) Pp. 22-25

https://doi.org/10.6340/KD.202103_33(1).0005

摘要

慢性腎臟病患者及透析病患，因有較高B型肝炎的感染風險及形成慢性帶原者的機率，目前各診療指引包括美國疫苗接種諮詢委員會建議（Recommendations of the Advisory Committee on Immunization Practices）與改善全球腎臟病預後組織指引（Kidney Disease: Improving Global Outcomes Guideline）皆建議做B型肝炎疫苗之預防接種以降低發病率及死亡率；而針對A型肝炎，目前僅建議針對高風險族群進行接種，包括：患有慢性肝病、曾經移植肝臟的病人、男男間性行為者或靜脈藥癮者及赴流行地區者。應考慮慢性腎臟病患者個別狀況，給予適當的肝炎疫苗施打建議。

關鍵字

疫苗 ； B型肝炎 ； A型肝炎 ； 慢性腎臟病

並列摘要

Patients with chronic kidney disease (CKD) and end-stage renal disease have a higher risk of hepatitis B infection and progress to the chronic carrier. According to the Advisory Committee on Immunization Practices and Kidney Disease: Improving Global Outcomes guidelines, hepatitis B vaccination was advised for those patients to decrease associated morbidity and mortality. Hepatitis A vaccination was only recommended for high-risk groups, including patients with chronic liver disease, liver transplant recipients, men who have sex with men, intravenous drug users, and epidemic-area visitors. For CKD patients, the recommendation of hepatitis vaccinations should be individualized.

並列關鍵字

vaccine ； hepatitis B ； hepatitis A ； chronic kidney disease